ClinicalTrials.gg
RecruitingNCT07116187Updated Aug 26, 2025

A Pilot Return-to-Work Cognitive Intervention After Stroke

An interventional study of Train-Your-Brain (TYB) Stroke Recovery Programme in Stroke, sponsored by National University of Singapore. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-08-26.

Sponsored by National University of Singapore · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
21 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 104 studies in Stroke with a site in Singapore — 16 open to participants now, 21 under way, 1 of them phase 3. Stroke · Singapore.

Planned enrollment
33rd of 86
100 · median 51
Started
2025
with 6 others
No phase
58 of 104
13 open now
Primary completion
2026-08
later than 6 of 20 live
Registered
95th of 104
by date
Lead sponsor
6 of 104
National University of Singapore

Among the 104 studies in Stroke with a site in Singapore, this one is the 33rd largest by planned enrollment of the 86 interventional ones that give a count, is one of 7 that started in 2025, is one of 58 with no phase, reaches primary completion later than 6 of the 20 other live ones, and was the 95th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

16 of the 104 studies in Stroke with a site in Singapore are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 21 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 104 studies in Stroke with a site in Singapore, or all of them as a file.
02

Study summary

This study addresses the growing burden of stroke in Singapore and highlights the lack of rehabilitation services for return to work after stroke. Despite functional physical recovery, many stroke survivors experience persistent impairments that hinder return-to-work. To bridge this gap, the study will implement a community-based brain health programme targeting cognitive and vocational outcomes in stroke survivors. Caregivers will also be included due to their critical support role. The study will assess the intervention's feasibility, acceptability, and its impact on cognitive function, return-to-work, neuroplasticity, psychosocial health, fatigue, and self-care.

Read the detailed description

Stroke is the fourth leading cause of death and the leading cause of adult disability in Singapore. Statistics indicate a concerning rise in young stroke cases. The burden of stroke care is expected to increase exponentially, posing significant challenges to the healthcare system and society. Cognitive impairment after stroke has been documented in up to one-third of stroke survivors. These impairments may be subtle but persistent and progressive even after the stroke survivor appears to have made functional recovery in other areas. Existing services in Singapore for stroke survivors typically target physical and daily functioning outcomes with little focus on cognitive functioning. Moreover, there is a lack of services for stroke survivors who face difficulties in returning to work due to cognitive impairment even when they have achieved optimal physical recovery. An important assessment of a rehabilitation intervention programme is in examining whether it drives positive neuroplasticity, which leads to improved cognitive and functional outcomes. There is presently a dearth of literature in brain mechanisms underlying the impact of cognitive rehabilitation.

A community-based brain health intervention, the Train-Your-Brain Stroke Recovery Programme, will be delivered by registered clinical neuropsychologists. Designed to enhance cognitive function and return-to-work outcomes in stroke survivors with mild cognitive impairment, the intervention will be evaluated using a mixed-methods randomized controlled trial. Stroke survivors will be randomized 1:1 into either the intervention or control arm. Caregivers, given their critical support role, will also be recruited to participate in the study. Outcome measures include feasibility of intervention, acceptability of intervention, cognitive function, return-to-work outcomes, changes in biomarkers, neuroimaging findings, psychosocial health, fatigue, and self-care. Outcome measures will be conducted pre-intervention, post-intervention, and 6-month follow-up.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Cognition
  • Return-to-work
  • Rehabilitation
  • Intervention
  • Community
  • Stroke survivors
  • Caregivers
04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria (for stroke survivors):

  • Between 21 to 65 years old
  • Ability to provide
  • Consent to recording / photo-taking
  • Living in the community with at least three months after stroke
  • Looking to return to work or switch jobs after stroke
  • No significant aphasia or physical disability issues which will impede them from performing cognitive tasks in the interventions and assessments
  • No major psychiatric illnesses
  • Able to understand and converse in English
  • Score on ≤22 and/or SDMT ≤13 (for those educated ≤6 years) or SDMT ≤32 (for those educated >6 years)
  • Meet criteria for Mild Cognitive Impairment based on the Vascular Dementia Battery

Inclusion Criteria (for caregivers):

  • At least 21 years old
  • Ability to provide informed consent
  • Consent to recording / photo-taking
  • Staying with or having knowledge of the stroke survivor's functioning
  • No major psychiatric illnesses
  • Able to understand and converse in English

Exclusion Criteria (for stroke survivors):

  • Less than 21 years old
  • More than 65 years old
  • Unable to provide informed consent
  • Refuse recording
  • Not living in the community and having less than three months after stroke
  • Significant aphasia or physical disability issues which will impede them from performing cognitive tasks in the interventions and assessments
  • Major psychiatric illnesses
  • Not able to understand and converse in English

Exclusion Criteria (for caregivers):

  • Less than 21 years old
  • Unable to provide informed consent
  • Refuse recording
  • Not staying with or not having knowledge of the stroke survivor's functioning
  • Major psychiatric illnesses
  • Not able to understand and converse in English
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Intervention Arm

    Participants will undergo the group-based Train-Your-Brain Stroke Recovery Programme.

    Other: Train-Your-Brain (TYB) Stroke Recovery Programme

  • No intervention
    Control Arm

    Participants will undergo treatment-as-usual from their respective treatment providers.

Interventions

  • OtherTrain-Your-Brain (TYB) Stroke Recovery Programme

    The intervention involves a structured brain health programme delivered by clinical neuropsychologists in three phases: an initial needs assessment, a multi-session intervention, and follow-up support. Participants will receive assessments, attend group sessions covering topics such as lifestyle, mood, cognition, and return-to-work strategies, and be supported with workbooks and referrals to community services. The programme combines in-person and online formats.

06

What researchers measure

Primary outcomes

  1. Number of eligible/ineligible participants

    Percentage of eligible/ineligible participants and reasons for ineligibility

    Time frame: Through study completion, an average of 6 months

  2. Recruitment and attrition rates

    Percentage of recruited participants and drop-outs

    Time frame: Through study completion, an average of 6 months

  3. VasCog Screen Test

    Test is comprised of a short-Montreal Cognitive Assessment (total score out of 12) and modified Symbol Digit Modalities Test (score calculated based on correct responses)

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  4. Vascular Dementia Battery

    Participants will meet criteria for Mild Cognitive Impairment if there is 1 or more domain(s) with failure in at least 50% of tasks in domain

    Time frame: Baseline (pre-intervention)

  5. National Institute of Neurological Disorders and Stroke - Canadian Stroke Network (NINDS-CSN) Stroke Protocol

    A test battery comprised of cognitive tests that are measured against their respective normative scores

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  6. Return-to-work Questionnaire (National Institute of Neurological Disorders and Stroke - Common Data Elements)

    Survey questions of participants' work status before and after stroke with check-box responses

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  7. Intervention fidelity

    Intervention Fidelity Checklist (eNACT Group Facilitation Competency Checklist) * "Observed - Done well" and "Observed - Done adequately" is equivalent to a score of 2; "Observed - Not done well" is equivalent to a score of 1; "Not observed - despite opportunity" is equivalent to a score of 0 * An overall score of 2 reflects adequate competence in group facilitation

    Time frame: During the intervention and immediately after the intervention

  8. Qualitative interviews

    Semi-structured interviews will be conducted with stroke survivors and family members to obtain feedback about their experiences of the intervention

    Time frame: Immediately after the intervention

  9. Participants' acceptability of the intervention

    Feedback forms provided after each intervention session rated on a 5-point response scale from Strongly Disagree to Strongly Agree

    Time frame: During the intervention

  10. Patient-Reported Outcomes Measurement Information System (PROMIS) - 10

    5-point response scale from Excellent (5) to Poor (1)

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  11. EuroQol 5-Dimension 5-Level (EQ-5D-5L)

    Survey questions of participants' Mobility, Self-care, Usual activities, Pain/discomfort, and Anxiety/depression with check-box responses across five levels of severity, ranging from no problems to extreme problems.

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  12. Fatigue Assessment Scale

    5-point response scale from Always (5) to Never (1)

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  13. Depression, Anxiety, Stress Scale

    3-point response scale from Did not apply to me at all (0) to Applied to me very much, or most of the time (3)

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  14. Zarit Burden Interview

    4-point response scale from Nearly Always (4) to Never (0)

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  15. Voils Domains Of Subjective Extent of Nonadherence

    Survey questions on participants' extent and reasons for nonadherence with check-box responses (None of the time, A little of the time, Some of the time, Most of the time, Every time)

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  16. Blood Pressure Measurement

    Measurement of participants' blood pressure reading

    Time frame: Baseline (pre-intervention), immediately after the intervention, 6-months follow-up

  17. Blood-Derived Neurotrophic Factor

    Blood biomarker derived from participants' blood samples

    Time frame: Immediately after the intervention, 6-months follow-up

  18. Functional near-infrared spectroscopy measurement

    Measurement of oxyhaemoglobin (HbO2), deoxyheemoglobin (HbR), and regional oxygen saturation (rSO2) while participants undergo various cognitive tests (e.g. N-back Task, verbal fluency test, Stroop Task)

    Time frame: Immediately after the intervention, 6-months follow-up

Secondary outcomes

  1. Cost Effectiveness Analysis Questionnaire

    Time frame: Immediately after the intervention, 6-months follow-up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All collected and deidentified IPD

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Aug 2026, 11 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 11 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2025
First posted
Aug 11, 2025
StartActual
Aug 8, 2025
Primary completionEst.
Aug 1, 2026
CompletionEst.
Dec 31, 2026
Last update
Aug 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07116187
Responsible party
Catherine Yanhong Dong, PhD (Assistant Professor, National University of Singapore) — Principal investigator
First posted
Aug 11, 2025
Start date
Aug 8, 2025
Primary completion
Aug 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 26, 2025

Study contacts

Yanhong Dong
Contact
nurdy@nus.edu.sg
65-65168686

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion